Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-01-03 @ 6:08 AM
Study NCT ID:
NCT03469804
Status:
UNKNOWN
Last Update Posted:
2019-10-21
First Post:
2018-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
P160601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None